Anxiety and Depression in People With Blood Cancers
Follows anxiety and depression over time in people with blood cancers.
Plain-language title generated from the registry record
Registry title: Study of Anxiety and Depression in Patients With Hematologic Malignancies
Key facts
- Where
- Xiamen, ChinaSee the site
Where in China
- the First Affilaited Hospital of Xiamen UniversityXiamen, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The First Affiliated Hospital of Xiamen University
- Trial code
- NCT07883070
- Record updated
- 5 November 2026
- Original description
Assessment of Anxiety and Depression Status in Patients with Hematologic MalignanciesRead full original descriptionShow less
An Observational Prospective Cohort Study of Anxiety and Depression in Patients With Hematologic Malignancies
Assessment of Anxiety and Depression Status in Patients with Hematologic Malignancies
Inclusion: Patients with hematologic malignancies who visit the Department of Hematology at the First Affiliated Hospital of Xiamen University from August 2026 onward, including lymphoma, multiple myeloma, and leukemia; Patients who are able to understand and voluntarily participate in anxiety and depression status assessments.
Exclusion: Patients with any other conditions considered by the investigator to be inappropriate for participation in this study.